Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
+$406M |
| 2 |
Baidu
BIDU
|
+$382M |
| 3 |
AGN
Allergan plc
AGN
|
+$366M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$322M |
| 5 |
NextEra Energy, Inc.
NEE
|
+$312M |
Top Sells
| 1 |
Tesla
TSLA
|
+$1.66B |
| 2 |
Meta Platforms (Facebook)
META
|
+$370M |
| 3 |
Pfizer
PFE
|
+$343M |
| 4 |
Gilead Sciences
GILD
|
+$331M |
| 5 |
Amazon
AMZN
|
+$282M |
Sector Composition
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.73% |
| 3 | Consumer Staples | 9.8% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Berry Corp
BRY
$257M
| $858K | ﹤0.01% |
+356,100
| New | +$858K |
|
2502
Hennessy Advisors
HNNA
$90.3M
| $856K | ﹤0.01% |
112,825
-10,900
| -9% | -$82.7K |
|
2503
Schwab US Dividend Equity ETF
SCHD
$71.5B
| $855K | ﹤0.01% |
+57,000
| New | +$855K |
|
2504
Resideo Technologies
REZI
$5.66B
| $854K | ﹤0.01% |
176,500
-13,700
| -7% | -$66.3K |
|
|
UXIN
2505
Uxin Ltd
UXIN
$722M
| $851K | ﹤0.01% |
5,526
+5,067
| +1,104% | +$780K |
|
2506
Kimbell Royalty Partners
KRP
$1.26B
| $848K | ﹤0.01% |
145,478
+44,884
| +45% | +$262K |
|
2507
Kura Oncology
KURA
$711M
| $848K | ﹤0.01% |
+85,271
| New | +$848K |
|
2508
Schwab US Large- Cap ETF
SCHX
$60.3B
| $845K | ﹤0.01% |
82,800
+30,600
| +59% | +$312K |
|
|
UBX
2509
DELISTED
Unity Biotechnology
UBX
| $838K | ﹤0.01% |
14,440
+11,440
| +381% | +$664K |
|
2510
Q32 Bio
QTTB
$23.5M
| $836K | ﹤0.01% |
+2,988
| New | +$836K |
|
|
SWAV
2511
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $836K | ﹤0.01% |
+25,200
| New | +$836K |
|
|
NUVA
2512
DELISTED
NuVasive, Inc.
NUVA
| $836K | ﹤0.01% |
16,500
-76,788
| -82% | -$3.89M |
|
|
NCNA
2513
NuCana
NCNA
$7.37M
| $834K | ﹤0.01% |
29
+12
| +71% | +$345K |
|
2514
Schwab US Broad Market ETF
SCHB
$36.8B
| $834K | ﹤0.01% |
82,800
-22,680
| -22% | -$228K |
|
|
SRRA
2515
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $834K | ﹤0.01% |
84,974
-1,438
| -2% | -$14.1K |
|
2516
Consumers Staples Select Sector SPDR Fund
XLP
$16B
| $828K | ﹤0.01% |
15,200
-152,200
| -91% | -$8.29M |
|
2517
SPDR S&P Regional Banking ETF
KRE
$4.24B
| $825K | ﹤0.01% |
+25,300
| New | +$825K |
|
2518
Oil States International
OIS
$341M
| $825K | ﹤0.01% |
406,500
+303,500
| +295% | +$616K |
|
2519
AdaptHealth
AHCO
$1.26B
| $824K | ﹤0.01% |
+51,500
| New | +$824K |
|
|
LOAN
2520
Manhattan Bridge Capital
LOAN
$61.3M
| $824K | ﹤0.01% |
201,531
-26,531
| -12% | -$108K |
|
2521
Biglari Holdings Class B
BH
$943M
| $823K | ﹤0.01% |
16,006
-5,570
| -26% | -$286K |
|
2522
Genco Shipping & Trading
GNK
$774M
| $822K | ﹤0.01% |
128,030
-115,300
| -47% | -$740K |
|
|
SMTX
2523
DELISTED
SMTC Corporation
SMTX
| $817K | ﹤0.01% |
350,433
-22,977
| -6% | -$53.6K |
|
2524
Kinsale Capital Group
KNSL
$10.1B
| $815K | ﹤0.01% |
+7,800
| New | +$815K |
|
2525
Core Molding Technologies
CMT
$182M
| $814K | ﹤0.01% |
528,463
-6,250
| -1% | -$9.63K |
|